about
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSEmerging Trends in Noninvasive Insulin DeliveryPharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to BloodPharmaceutical particle engineering via spray drying.Entrapment enhancement of peptide drugs in niosomes.Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas.Needle-free injection of insulin powder: delivery efficiency and skin irritation assessment.A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitusIntradermal insulin delivery: a promising future for diabetes management.Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetesInhaled insulin: Exubera.Novel preparation of PLGA/HP55 nanoparticles for oral insulin delivery.Commercial challenges of protein drug delivery.Delivery of parathyroid hormone for the treatment of osteoporosis.Noninvasive delivery technologies: respiratory delivery of vaccines.Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.Inhaled insulin delivery--where are we now?Peptides targeting protein kinases: strategies and implications.Inhaled insulin (Exubera): Combining efficacy and convenience.Inhaled insulins.Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.Nanoparticle strategies for the oral delivery of insulin.Serum insulin aspart concentrations following high-dose insulin aspart administered directly into the duodenum of healthy subjects: an open-labeled, single-blinded, and uncontrolled exploratory trial.Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.Recent challenges in insulin delivery systems: a review.Oral insulin and buccal insulin: a critical reappraisal.Microneedles: a valuable physical enhancer to increase transdermal drug delivery.Strategies for non-invasive delivery of biologics.Noninvasive insulin delivery: the great potential of cell-penetrating peptides.Drug transport mechanism of oral antidiabetic nanomedicines.Recent advances in childhood diabetes mellitus.Newer devices and improved formulations of inhaled insulin.Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells.Developing accurate models of the human airways.How to overcome the limitations of current insulin administration with new non-invasive delivery systems.Why most oral insulin formulations do not reach clinical trials.Pursuit of a perfect insulin.
P2860
Q21129334-9A212DE5-5910-45BA-8460-B8918262ABD8Q27024335-F263ACC8-7588-47A5-986A-64FD5D74740DQ30300391-D83DD412-00AD-455D-B6D2-0E81906B89DEQ30496354-7311D54A-6846-466B-82FC-BEB00E744DD4Q33527532-A5FD0BF6-32C8-41D6-A7C0-B9C8EC3DFF0BQ33856010-F4CCB8DA-D41D-4172-89BD-8AB74BE617A3Q34245943-82CF6976-1286-48EB-A25A-BDD44DCD8BB9Q34360945-8353DC2D-DD7D-47BA-9965-6C1806313378Q35682776-E7757B43-32AB-4F26-AFA2-871DA8970A1FQ35682783-341FC155-5180-4141-9EB4-48FCBD853A9FQ35743439-A4925098-70A0-42AB-9BA9-01B100C2C57EQ35826982-95580FF3-C6D4-4DCF-A17B-1302E1DAA541Q35876380-7E66B66A-44F3-47D3-905B-A7E7C2317815Q36096727-FBD44DEB-7E89-4DFB-9E09-2EC0211BEFCAQ36218161-6472C306-D5C2-49B4-B56F-21E7E4E751F8Q36316655-633B5F79-0556-4E6E-B341-2069CBCF7694Q36316910-D7A67D39-CA84-4DD1-9C15-A2C1A720EEEAQ36349694-402FCA6C-AC30-47A6-9F5C-264E9D4C9222Q36521858-E4EE120B-570F-4206-9C35-18F1EB3104CAQ36616573-5E7209B6-E655-47C6-B7C5-F7A78F95CFE6Q36659979-FA22A321-E327-4866-93F0-E5093CA70A78Q36679610-652EDCDE-9F9B-442F-80E5-6D7627C2FF1BQ36754100-CBCEBC5D-E5D0-43C1-8C59-A81CF7C0A87EQ36856384-0CC29D0C-6710-4705-8CDB-53597D23C37EQ37039026-B291F4E0-544E-4528-8D8A-587A14E28383Q37404491-7FBC4471-7758-434D-B3EC-5C1B87A741CCQ37436438-F23E1A5E-750D-4A4A-AE9F-A087065A68F7Q37472722-8E54B833-3742-4E88-AEFB-3186C7922519Q37689833-093F5071-EEC5-4CE0-8220-30A195F26BA3Q37819486-F955563B-7EB8-4BC8-AE5B-1AE890126F6BQ38013190-28D86DE5-5916-4FFC-91BF-A7D93ED53CD5Q38084736-315B8C31-4F94-40F7-A346-D9D9B4781D15Q38201717-FA59513D-316E-424A-AACA-11FDE7248E79Q38243785-8CF18AC5-08AB-4B69-B53D-E0AA90E576F2Q38285092-9A642BA1-A8E3-437F-8E0C-F3E5633CDAD0Q38286395-77BA1A6D-F973-4F08-BFAD-E8589C060D8BQ38306418-E7E428E1-FEB5-4EFC-B65F-8CCA586257BDQ38309884-7564A20B-2B0D-46D4-8653-C57BC5D36CCDQ38566437-D71D0801-234B-47FD-8583-EED50751D932Q38778988-1A585127-93B1-4221-944E-2575F7AEFCC1
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Alternative routes of insulin delivery.
@ast
Alternative routes of insulin delivery.
@en
type
label
Alternative routes of insulin delivery.
@ast
Alternative routes of insulin delivery.
@en
prefLabel
Alternative routes of insulin delivery.
@ast
Alternative routes of insulin delivery.
@en
P2093
P2860
P1433
P1476
Alternative routes of insulin delivery.
@en
P2093
P2860
P304
P356
10.1046/J.1464-5491.2003.01076.X
P577
2003-11-01T00:00:00Z